|
Index of reports
> Cases resulting in a serious event (505)
> Cases with Abdominal Pain (30)
Below is the selection of adverse event reports related to Fluorouracil that includes cases resulting in a serious event where reactions include abdominal pain.
Reports 1 - 25 of 30 Next >>
Adverse event in female receiving Fluorouracil
Reported by a physician from United Kingdom on 2007-10-25
Patient: female, weighing 137.8 kg (303.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Vomiting, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 312.5 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Oxaliplatin
Dosage: 140 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Leucovorin
Dosage: 660 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Fluorouracil
Dosage: 660 mg, q2w
Indication: Colon Cancer
Start date: 2007-04-23
Other drugs received by patient: Neupogen; Modulon; Iron Supplement
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Jaundice, Metastatic Neoplasm, Bile Duct Obstruction, Malignant Neoplasm Progression, Hepatic Failure, Oedema Peripheral, Abdominal Distension, Decreased Appetite, Lethargy
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Fluorouracil
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-04
Leucovorin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-03
Oxaliplatin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
Aranesp
Indication: Anaemia
Avastin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
Avastin
Dosage: unk
Adverse event in female receiving Fluorouracil
Reported by a physician from United States on 2007-10-19
Patient: female, weighing 130.2 kg (286.4 pounds)
Adverse reactions / side effects: Abdominal Pain, Vomiting, Nausea, Heart Rate Increased, Pancytopenia, Neutropenia, Pyrexia, Blood Pressure Decreased
Suspect drug(s):
Leucovorin
Indication: Colon Cancer Stage III
Start date: 2006-07-30
End date: 2006-07-30
Eloxatin
Indication: Colon Cancer Stage III
Start date: 2007-01-01
End date: 2007-01-01
Fluorouracil
Indication: Colon Cancer Stage III
Start date: 2006-07-30
End date: 2006-07-30
Other drugs received by patient: Aranesp; Neupogen; Restoril; Ambien; Lunesta; Lantus; Avandia; Zestril; Glucotrol; Glucophage; Zocor; Dexamethasone 0.5mg TAB; Zofran
Adverse event in female receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19
Patient: female, weighing 57.6 kg (126.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Empty Sella Syndrome, Diarrhoea, Septic Shock, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Oxaliplatin
Indication: Colorectal Cancer
Start date: 2007-07-25
End date: 2007-07-25
Leucovorin
Indication: Colorectal Cancer
Fluorouracil
Indication: Colorectal Cancer
Other drugs received by patient: Lipitor; Hydrochlorothiazide; Xanax
Adverse event in female receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-19
Patient: female, weighing 76.7 kg (168.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Fatigue, Vomiting, Diarrhoea, Nausea, Anorexia, Dizziness, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Fluorouracil
Dosage: 1448 mg
End date: 2007-10-04
Bevacizumab (Rhumab Vegf)
Dosage: 380 mg
End date: 2007-10-04
Leucovorin Calcium
Dosage: 1448 mg
End date: 2007-10-04
Eloxatin
Dosage: 308 mg
End date: 2007-10-04
Adverse event in female receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-10-12
Patient: female, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Large Intestine Perforation, Dysuria, Diverticulum Intestinal
Adverse event resulted in: hospitalization
Suspect drug(s):
Fluorouracil
Dosage: 2642 mg
End date: 2007-09-18
Bevacizumab (Rhumab Vegf)
Dosage: 340 mg
End date: 2007-09-18
Camptosar
Dosage: 166 mg
End date: 2007-09-18
Leucovorin Calcium
Dosage: 680 mg
End date: 2007-09-18
Adverse event in 40 year old female receiving Fluorouracil
Reported by a physician from United States on 2007-10-11
Patient: 40 year old female
Adverse reactions / side effects: Abdominal Pain, Headache, Constipation, Palpitations, Chest Pain, Photophobia, Abdominal Distension, Blindness Transient, Vomiting, Pain in Extremity, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Atrial Fibrillation, Mucosal Inflammation, Visual Disturbance, Hypertension, Asthenia, Neuralgia
Suspect drug(s):
Folinic Acid
Indication: Colon Cancer Stage III
Folinic Acid
Fluorouracil
Indication: Colon Cancer Stage III
Fluorouracil
Fluorouracil
Dosage: 2400mg/m2 over a 46-hour continuous infusion
Eloxatin
Dosage: 85 mg/m2 infusion on alternating weeks
Indication: Colon Cancer Stage III
Other drugs received by patient: Metroprolol; Magnesium Sulfate; Decadron; Ondansetron; Ondansetron; Diphenhydramine HCL; Famotidine; Palonosetron; Calcium Gluconate
Adverse event in male receiving Fluorouracil
Reported by a consumer/non-health professional from United Kingdom on 2007-10-08
Patient: male, weighing 92.0 kg (202.4 pounds)
Adverse reactions / side effects: Abdominal Pain, Oesophagitis, Febrile Neutropenia, Gastritis, Lower Respiratory Tract Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 460 mg, q2w
Indication: Colon Cancer
Start date: 2005-12-13
End date: 2006-03-21
Oxaliplatin
Dosage: 178 mg, q2w
Indication: Colon Cancer
Start date: 2005-12-13
Oxaliplatin
Dosage: 157.5 mg, unk
Start date: 2006-03-21
Fluorouracil
Dosage: 840 mg, unk
Indication: Colon Cancer
Start date: 2005-12-13
Fluorouracil
Dosage: 630 mg, unk
Start date: 2006-03-21
Fluorouracil
Dosage: 1050 mg, unk
Leucovorin
Dosage: 420 mg, unk
Indication: Colon Cancer
Start date: 2005-12-13
Other drugs received by patient: Neorecormon
Adverse event in receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-05
Patient:
Adverse reactions / side effects: Abdominal Pain, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Leucovorin
Indication: Drug USE FOR Unknown Indication
Fluorouracil
Indication: Drug USE FOR Unknown Indication
Oxaliplatin
Indication: Drug USE FOR Unknown Indication
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-07-25
Patient: male
Adverse reactions / side effects: Jaundice, Abdominal Pain
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 350 mg, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2006-12-06
Fluorouracil
Dosage: 3560 mg, unk
Indication: Chemotherapy
Start date: 2006-06-04
Calcium Folinate
Indication: Chemotherapy
Other drugs received by patient: Lansoprazole; Ursodiol; Zofran
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-07-17
Patient: male
Adverse reactions / side effects: Jaundice, Abdominal Pain
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 350 mg, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2006-12-06
Fluorouracil
Dosage: 3560 mg, unk
Indication: Chemotherapy
Start date: 2006-06-04
Calcium Folinate
Indication: Chemotherapy
Other drugs received by patient: Lansoprazole; Ursodiol; Zofran
Adverse event in 58 year old male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-07-12
Patient: 58 year old male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Abdominal Pain, Angina Pectoris, Intestinal Obstruction, Constipation, Haemoglobin Decreased, Haematocrit Decreased, Enterovesical Fistula, Sleep Disorder, Colorectal Cancer Metastatic, Blood Cholesterol, Bladder Disorder, Blood Sodium Decreased, Arteriosclerosis, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Ciprofloxacin HCL
Dosage: total daily dose: 250 mg unit dose: 250 mg
Administration route: Oral
Indication: Prophylaxis
Aspirin
Dosage: total daily dose: 81 mg unit dose: 81 mg
Administration route: Oral
Indication: Prophylaxis
Start date: 1986-01-01
End date: 2003-08-10
Irinotecan HCL
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Irinotecan HCL
Start date: 2003-08-18
End date: 2003-08-18
Fluorouracil
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Fluorouracil
Start date: 2003-08-18
End date: 2003-08-18
Xanax
Dosage: total daily dose: 0.5 mg
Administration route: Oral
Indication: Sleep Disorder
Leucovorin Calcium
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-18
Toprol-XL
Dosage: total daily dose: 50 mg
Administration route: Oral
Indication: Hypertension
Zetia
Dosage: total daily dose: 10 mg
Administration route: Oral
Indication: Hypercholesterolaemia
Protonix
Dosage: total daily dose: 40 mg
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Amiodarone HCL
Dosage: total daily dose: 400 mg
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-22
Patient: male, weighing 83.4 kg (183.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Dehydration, Diverticulitis, Abdominal Distension, Constipation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, days 1+22
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Paclitaxel
Dosage: 200 mg/m2, days 1+22
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Carboplatin
Dosage: 6 auc, days 1+22
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Fluorouracil
Dosage: 200 mg/m2, unk
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Other drugs received by patient: Wellbutrin; Digitek; Zocor; Insulin; Actos
Adverse event in male receiving Fluorouracil
Reported by a physician from United States on 2007-06-19
Patient: male, weighing 78.5 kg (172.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Diverticulitis, Diverticular Perforation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Carboplatin
Dosage: 6 auc, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Paclitaxel
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Fluorouracil
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Other drugs received by patient: Digoxin; Famotidine; Meropenem; Flagyl; Acetaminophen; Fentanyl; Glucagon; Regular Insulin; Lorazepam; Morphine; Zofran; Propofol; Sodium Chloride; Cefoxitin; Lidocaine; Wellbutrin; Zocor; Lantus; Actos
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-12
Patient: male, weighing 83.4 kg (183.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Dehydration, Diverticulitis, Abdominal Distension, Constipation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, days 1+22
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Paclitaxel
Dosage: 200 mg/m2, days 1+22
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Carboplatin
Dosage: 6 auc, days 1+22
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Fluorouracil
Dosage: 200 mg/m2, unk
Indication: Squamous Cell Carcinoma
Start date: 2007-04-02
End date: 2007-05-10
Other drugs received by patient: Wellbutrin; Digitek; Zocor; Insulin; Actos
Adverse event in male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-05-31
Patient: male, weighing 80.4 kg (176.9 pounds)
Adverse reactions / side effects: Abdominal Pain, Large Intestine Perforation, Dyspnoea, Vomiting, Nausea, Gastrointestinal Disorder, Hiccups, Pneumoperitoneum
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab (Rhumab Vegf)
Dosage: 402 mg
Leucovorin Calcium
Dosage: 736 mg
Eloxatin
Dosage: 156 mg
Fluorouracil
Dosage: 5152 mg
Adverse event in male receiving Fluorouracil
Reported by a physician from United States on 2007-05-31
Patient: male, weighing 78.5 kg (172.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Diverticulitis, Diverticular Perforation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Carboplatin
Dosage: 6 auc, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Paclitaxel
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Fluorouracil
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Other drugs received by patient: Digoxin; Famotidine; Meropenem; Flagyl; Acetaminophen; Fentanyl; Glucagon; Regular Insulin; Lorazepam; Morphine; Zofran; Propofol; Sodium Chloride; Cefoxitin; Lidocaine; Wellbutrin; Zocor; Lantus; Actos
Adverse event in male receiving Fluorouracil
Reported by a physician from United States on 2007-05-24
Patient: male, weighing 78.5 kg (172.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Diverticulitis, Diverticular Perforation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Carboplatin
Dosage: 6 auc, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Paclitaxel
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Fluorouracil
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Other drugs received by patient: Digoxin; Famotidine; Meropenem; Flagyl; Acetaminophen; Fentanyl; Glucagon; Regular Insulin; Lorazepam; Morphine; Zofran; Propofol; Sodium Chloride; Cefoxitin; Lidocaine; Wellbutrin; Zocor; Lantus; Actos
Adverse event in male receiving Fluorouracil
Reported by a physician from United States on 2007-05-15
Patient: male, weighing 78.5 kg (172.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Diverticulitis, Diverticular Perforation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Carboplatin
Dosage: 6 auc, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Paclitaxel
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Fluorouracil
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Other drugs received by patient: Digoxin; Famotidine; Meropenem; Flagyl; Acetaminophen; Fentanyl; Glucagon; Regular Insulin; Lorazepam; Morphine; Zofran; Propofol; Sodium Chloride; Cefoxitin; Lidocaine; Wellbutrin; Zocor; Lantus; Actos
Adverse event in male receiving Fluorouracil
Reported by a physician from United States on 2007-05-09
Patient: male, weighing 78.5 kg (172.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Diverticulitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Carboplatin
Dosage: 6 auc, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Paclitaxel
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Fluorouracil
Dosage: 200 mg/m2, unk
Indication: Neoplasm Malignant
Start date: 2007-04-02
Other drugs received by patient: Digoxin; Famotidine; Meropenem; Flagyl; Acetaminophen; Fentanyl; Glucagon; Regular Insulin; Lorazepam; Morphine; Zofran; Propofol; Sodium Chloride; Cefoxitin; Lidocaine
Adverse event in 67 year old male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-02
Patient: 67 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Confusional State, Vomiting, Diarrhoea, Disorientation, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 305 mg, unk
Indication: Colorectal Cancer Metastatic
Start date: 2006-11-09
Avastin
Dosage: 152.5 mg, unk
Start date: 2007-02-15
Camptosar
Dosage: 302 mg, unk
Indication: Colorectal Cancer Metastatic
Start date: 2006-11-09
Camptosar
Dosage: 151 mg, unk
Start date: 2007-02-15
Fluorouracil
Dosage: 672 mg, unk
Indication: Colorectal Cancer Metastatic
Start date: 2006-11-09
Fluorouracil
Dosage: 1008 mg, unk
Fluorouracil
Dosage: 336 mg, unk
Start date: 2007-02-15
Fluorouracil
Dosage: 504 mg, unk
Elvorine
Dosage: 168 mg, unk
Indication: Colorectal Cancer Metastatic
Start date: 2006-11-09
Elvorine
Dosage: 84 mg, unk
Start date: 2007-02-15
Other drugs received by patient: Prograf; Fentanyl; Morphine; Mixtard Human 70 / 30
Adverse event in 58 year old male receiving Fluorouracil
Reported by a individual with unspecified qualification from United States on 2007-04-17
Patient: 58 year old male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Abdominal Pain, Angina Pectoris, Intestinal Obstruction, Constipation
Adverse event resulted in: hospitalization
Suspect drug(s):
Ciprofloxacin HCL
Dosage: total daily dose: 250 mg unit dose: 250 mg
Administration route: Oral
Indication: Prophylaxis
Acetylsalicylic Acid SRT
Dosage: total daily dose: 81 mg unit dose: 81 mg
Administration route: Oral
Indication: Prophylaxis
Start date: 1986-01-01
End date: 2003-08-10
Irinotecan HCL
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Irinotecan HCL
Start date: 2003-08-18
End date: 2003-08-18
Fluorouracil
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Fluorouracil
Start date: 2003-08-18
End date: 2003-08-18
Xanax
Dosage: total daily dose: 0.5 mg
Administration route: Oral
Indication: Sleep Disorder
Leucovorin Calcium
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-18
Toprol-XL
Dosage: total daily dose: 50 mg
Administration route: Oral
Indication: Hypertension
Zetia
Dosage: total daily dose: 10 mg
Administration route: Oral
Indication: Hypercholesterolaemia
Protonix
Dosage: total daily dose: 40 mg
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Amiodarone HCL
Dosage: total daily dose: 400 mg
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) on 2007-03-30
Patient: male, weighing 71.7 kg (157.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Vomiting, Mental Status Changes, Disease Progression
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Fluorouracil
Start date: 2007-02-08
End date: 2007-02-08
Leucovorin Calcium
Start date: 2007-02-08
End date: 2007-02-08
Sutent
Administration route: Oral
Start date: 2007-02-08
End date: 2007-02-09
Oxaliplatin
Indication: Pancreatic Carcinoma Metastatic
Start date: 2007-02-08
End date: 2007-02-08
Other drugs received by patient: Milk OF Magnesia; Nexium; Zofran; Mylanta; Colace; GAS-X; Proctosol-HC; Anusol HC; Vitamin CAP; Megace; Oxycontin; Oxycodone HCL; Pancrease; Miralax
Adverse event in 58 year old male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-23
Patient: 58 year old male, weighing 71.7 kg (157.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Calcium Decreased, Haemoglobin Decreased, Vomiting, Urine Output Decreased, General Physical Health Deterioration, Mental Status Changes, Disease Progression
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Fluorouracil
Dosage: 400 mg/m2 every two weeks (400 mg/m2), intravenous
Indication: Pancreatic Carcinoma Metastatic
Start date: 2007-02-08
End date: 2007-02-10
Folinic Acid
Dosage: 400 mg/m2 every two weeks 400 mg/m2)
Indication: Pancreatic Carcinoma Metastatic
Start date: 2007-02-08
Sutent
Dosage: 37.5 mg/day, oral
Administration route: Oral
Indication: Pancreatic Carcinoma Metastatic
Start date: 2007-02-08
End date: 2007-02-09
Oxaliplatin
Dosage: 8.5 mg/m2 every two weeks (8.5 mg/m2), intravenous
Indication: Pancreatic Carcinoma Metastatic
Start date: 2007-02-08
Other drugs received by patient: Macrogol; Pancreatin Triple Strength CAP; Oxycodone HCL; Oxycodone HCL; Megestrol Acetate; Dimeticone, Activated; Proctosol; Anusol; Mylanta; Ondansetron; Magnesium Hydroxide TAB; Multi-Vitamin; ..
Adverse event in 71 year old male receiving Fluorouracil
Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-22
Patient: 71 year old male, weighing 65.3 kg (143.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Pain
Adverse event resulted in: death
Suspect drug(s):
Avastin
Dosage: 552 mg, q2w, intravenous
Indication: Colorectal Cancer Metastatic
Start date: 2006-12-06
End date: 2007-02-12
Cetuximab (Cetuximab)
Dosage: 470 mg, 1/week, intravenous
Indication: Colorectal Cancer Metastatic
Start date: 2006-12-06
End date: 2007-02-12
Fluorouracil
Dosage: see image
Indication: Colorectal Cancer Metastatic
Start date: 2006-12-06
End date: 2007-02-12
Fluorouracil
Dosage: see image
Indication: Colorectal Cancer Metastatic
Start date: 2006-12-06
End date: 2007-02-12
Leucovorin Calcium
Dosage: 752 mg, q2w, intravenous
Indication: Colorectal Cancer Metastatic
Start date: 2006-12-06
End date: 2007-02-12
Other drugs received by patient: Benicar; Norvasc; Vicodin
Page 1 Next >>
|
